I Stock 1018468972

We provide end-to-end (bio)analytical support to drug development from pre-clinical up to Phase IV studies.

PRA recognizes that the world of drug development is complex and dynamic. That's why we designed two fully harmonized laboratories to meet every challenge. We offer the highest quality services for pharmacokinetic, immunogenicity, biomarker, and CMC analysis, utilizing a wide range of platforms for small molecules, large molecules, and cell-based entities. PRA's Laboratories for Drug Development are managed, staffed, and supported by industry-leading experts who have the scientific knowledge and experience necessary to successfully deliver the most complex of studies.

We believe that transparency is key when it comes to complex laboratory services. Our industry leading experts are always transparent throughout a study and immediately communicate what's going on. We deliver good news swiftly and bad news even faster, proactively solving any challenges and keeping your research on track.

The proximity of our labs to PRA's clinics enables us to analyze time-critical samples with short turnaround times. This allows us to advance your studies to the next phase faster than ever before.

Peter Ketelaar, Vice President, Laboratory Services

We’re enabling faster drug development decision-making.

Our GLP & GMP compliant facilities in the USA and the Netherlands adhere to the latest global regulatory guidelines and industry expectations. Our investments in technology and innovative service offerings are key components to developing optimal solutions for our clients.

Lenexa, Kansas, USA

Our Lenexa laboratory offers specialized and complex services that span the entire development spectrum, including large and small molecule pharmacokinetic (PK) and pharmacodynamic (PD) sample analysis. This includes:

  • LC/MS/MS
  • HPLC analysis
  • PK, PD, and immunogenicity testing (ADA) via ELISA
  • MSD
  • Imperacer

Assen, The Netherlands

Our rapidly growing laboratory in Assen is uniquely positioned to execute global studies at the local level. In addition to LCMS, LBA, GMP, and ADME services, we also offer Flow Cytometry to support early efficacy determinations in early Phase I studies all the way through Proof of Concept and multi-site clinical trials.

The Assen lab also has a fully equipped clinical chemistry laboratory for safety and efficacy analysis, and a quality control laboratory to support our GMP pharmacy. Additionally, they are equipped for C-14 and other isotopic radioactivity counting for mass balance studies.

We offer an end-to-end solution to take your product from concept to compound to cure.

Over the last 40 years, we’ve built up our world-class ecosystem of expertise and capabilities to offer you an end-to-end solution to get your product from concept to compound to cure. We’ve seen—and done—it all. We’ve earned the knowledge that empowers us to proactively prevent common challenges and unexpected hurdles that could get in-between you and successful outcomes. No matter where you are in your product lifecycle, our Integrated Drug Development Solutions will partner with you to safely and effectively guide you to success.

Pushing research forward with specialized assay development

We offer specialized assay development in addition to non-proprietary assays, as well as validation to meet your specific needs, including PK, efficacy, and immunogenicity assays for both small and large molecules.

Learn more about PRA's bioanalytical laboratories

Start a conversation

You may also be interested in: